Stay updated on Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page.
Latest updates to the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check31 days agoChange DetectedThe Locations section now lists Minnesota as a study site. The Minnesota Locations entry and the HHS Vulnerability Disclosure section were removed, and the page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.2%
- Check52 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check59 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1 on the page, reflecting a metadata version change. This does not modify study content or user-facing details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check66 days agoChange DetectedRemoved the temporary funding-status notice banner from the page. Core study information and links remain unchanged.SummaryDifference0.3%
- Check80 days agoChange DetectedResults have been posted for the study, and the record now includes updated study dates, status, and outcome measures. This adds visibility into trial findings and current completion status.SummaryDifference0.3%
- Check109 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%
Stay in the know with updates to Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page.